Author Login

• Research Article
• Open Access
• Elesis Vaass

Apolipoprotein E malfunction caused by a genetic mutation in combination with other metabolic variables results in residual lipoproteins building up in the plasma, a condition known as dysbetalipoproteinemia (DBL).

• Research Article
• Open Access
• Mikole Keisch

Individuals who have 21-hydroxylase deficiency-related classic congenital adrenal hyperplasia (CAH) need cortisol replacement therapy for the rest of their lives.

• Commentary
• Open Access
• Pars Jävendah

The daily injections required for current GH therapy can be taxing. A long-acting GH derivative called somapacitan is being developed to treat GH deficit (GHD).

• Research Article
• Open Access
• Asabel Nenezes

Although COVID-19 is a prothrombotic and proinflammatory illness, its effects on adrenal function have not been sufficiently studied.

• Commentary
• Open Access
• David A. D’Alessio

Glucagon-like peptide 1 (GLP-1) receptor agonists are effective and safe weight-loss medications, according to recent data from clinical trials. GLP-1 receptor agonists were initially created as medications to lower blood sugar levels in individuals with type 2 diabetes.